Paul Peter Tak
Paul Peter Tak
GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam University Medical Center
No verified email - Homepage
Cited by
Cited by
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ...
Arthritis & rheumatism 62 (9), 2569-2581, 2010
NF-κB: a key role in inflammatory diseases
PP Tak, GS Firestein
The Journal of clinical investigation 107 (1), 7-11, 2001
Ankylosing spondylitis
J Braun, J Sieper
The Lancet 369 (9570), 1379-1390, 2007
Micro-magnetofluidics: interactions between magnetism and fluid flow on the microscale
NT Nguyen
Microfluidics and nanofluidics 12 (1-4), 1-16, 2012
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review
D Tracey, L Klareskog, EH Sasso, JG Salfeld, PP Tak
Pharmacology & therapeutics 117 (2), 244-279, 2008
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ...
Nature 506 (7488), 376-381, 2014
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
EA Stahl, S Raychaudhuri, EF Remmers, G Xie, S Eyre, BP Thomson, Y Li, ...
Nature genetics 42 (6), 508, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
W Hueber, DD Patel, T Dryja, AM Wright, I Koroleva, G Bruin, C Antoni, ...
Science translational medicine 2 (52), 52ra72-52ra72, 2010
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Y Tang, X Luo, H Cui, X Ni, M Yuan, Y Guo, X Huang, H Zhou, N de Vries, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
PP Tak, TJM Smeets, MR Daha, PM Kluin, KAE Meijers, R Brand, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ...
Annals of the rheumatic diseases 66 (7), 921-926, 2007
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
GJ Wolbink, M Vis, W Lems, AE Voskuyl, E De Groot, MT Nurmohamed, ...
Arthritis & Rheumatism 54 (3), 711-715, 2006
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
S Raychaudhuri, EF Remmers, AT Lee, R Hackett, C Guiducci, NP Burtt, ...
Nature genetics 40 (10), 1216-1223, 2008
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis
PP Tak, B Bresnihan
Arthritis & Rheumatism 43 (12), 2619-2633, 2000
Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
PP Tak, PC Taylor, FC Breedveld, TJM Smeets, MR Daha, PM Kluin, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1996
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
P Geborek, A Bladström, C Turesson, A Gulfe, IF Petersson, T Saxne, ...
Annals of the Rheumatic Diseases 64 (5), 699-703, 2005
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ...
Annals of the rheumatic diseases 64 (6), 834-838, 2005
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
FA Koopman, SS Chavan, S Miljko, S Grazio, S Sokolovic, PR Schuurman, ...
Proceedings of the National Academy of Sciences 113 (29), 8284-8289, 2016
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
E Keystone, P Emery, CG Peterfy, PP Tak, S Cohen, MC Genovese, ...
Annals of the rheumatic diseases 68 (2), 216-221, 2009
The system can't perform the operation now. Try again later.
Articles 1–20